Xbrane Biopharma to participate at Redeye Biosimilar/Drug Delivery 16 April

Corporate Information

English

IR

mfn-ci-other

News

Xbrane Biopharma AB (publ) ("Xbrane" or "the Company”) represented by Martin Åmark, CEO, will tomorrow participate at Redeye’s capital markets day about Biosimilar/Drug Delivery.

On April 16, at 09:55 AM, Martin Åmark, CEO, Xbrane Biopharma, will present the latest events and development in the Company at Redeye. The presentation will be live and can be followed at https://www.redeye.se/events#/event/585887 where the presentation afterwards will be available on Xbrane’s company page at Redeye Universe https://www.redeye.se/company/xbrane-biopharma.